Last reviewed · How we verify

NCT05493384

Telerehabilitation in Rheumatic Diseases

Status unknown NA Last updated 9 August 2022
What this trial tests

NA trial testing Telerehabilitation Group in Telerehabilitation in 30 participants. Status unknown.

Timeline
25 July 2022
Primary endpoint
20 October 2022
20 November 2022

Quick facts

Lead sponsorGazi University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date25 July 2022
Primary completion20 October 2022
Estimated completion20 November 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gazi University

Who can join

Adults 18 to 65, any sex, with Telerehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Telerehabilitation (TR) became more popular during COVID-19 pandemic due to social isolation and curfew. Exercise is one of treatments for patients with rheumatic diseases that are known to have low levels of physical activity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Telerehabilitation Group

Trials testing the same drug.

Other recruiting trials for Telerehabilitation

Currently open trials in the same condition.

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05493384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing